Riyadh — Mubasher: Nahdi Medical Company’s board of directors has approved the distribution of SAR 338 million in cash dividends to shareholders for the first half (H1) of 2026.
The payout will be distributed across 130 million eligible shares, resulting in a per-share dividend of SAR 2.60.
The distribution, which was ratified during the 28 July 2026 board meeting, represents 26% of the company’s nominal share value.
According to the company disclosure, eligibility for the H1-26 dividends is set for 13 August 2026 for shareholders registered with the Securities Depository Center Company at the end of the second trading day following the eligibility date.
The dividend payment process, meanwhile, is scheduled to commence on 26 August 2026.
Nahdi Medical noted that funds will be deposited automatically into investment accounts linked to shareholder portfolios.
The company added that distributions to non-resident foreign investors will be subject to a 5% withholding tax in accordance with Article 68 of the Income Tax Law and Article 63 of its Implementing Regulations.
Shareholders are encouraged to update their bank account data to ensure timely receipt of payments.
In H1-26, Nahdi Medical registered net profits of SAR 450.90 million and revenue worth SAR 5.47 billion.
